Many people with long-standing high blood pressure develop heart failure. But some don’t. Daniel P. Kelly, M.D., and colleagues at Washington University School of Medicine in St. Louis and other institutions are trying to figure out what could explain that difference.
At menopause, women lose hormone protection against heart (cardiovascular) and kidney (renal) diseases, and are likely to become obese. A research team has tested the idea that estrogen deficiency in aged females may trigger the development of high blood pressure and obesity.
Many common diseases exhibit gender bias and gender differences have been observed in the development of high blood pressure (hypertension) and heart (cardiovascular) disease.
Menopausal women are at relatively high risk for memory loss, high blood pressure (hypertension) and diabetes. A decade ago, the standard treatment for these problems was long-term hormone replacement therapy (HRT). Since then, studies have shown that extensive use of HRT is associated with significant adverse effects.
For decades, older women have taken hormone replacements to replenish estrogen and progesterone levels lost to aging. More recently, testosterone (the most important male hormone) supplements have been used by aging men to improve their muscle mass, bone strength, libido and quality of life.
Danish researchers have examined the urinary patterns of sleep-deprived volunteers and have found that a lack of sleep leads to increased urinary output and more salt in urine. The findings were found to be more prevalent in males than females.
In a new study, researchers examined the differential contribution of genetic factors involved in regulating blood pressure based on samples drawn from a large community. They found significant differences in genetic contributors to blood pressure in males vs. females.
At menopause, women lose hormone protection against heart (cardiovascular) and kidney (renal) diseases, and are likely to become obese. A research team has tested the idea that estrogen deficiency in aged females may trigger the development of high blood pressure and obesity. The results of their study, using an animal model, suggest that estrogen depletion can have these effects.
An international trial looking at the benefits of giving blood-pressure lowering medication to elderly patients has stopped early, after researchers observed significant reductions in overall mortality in those receiving treatment.
The National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health (NIH), announced the launch of a new community education program, which broadens the Institute?s national stroke education campaign Know Stroke. Know the Signs. Act in Time. to promote stroke awareness among Hispanics in the United States.